Formula fed calf serum is a vital component in animal reproduction, as it stimulates the development of new embryos. There are several benefits of this serum, including the ability to induce fertilization. The production of fetal serum has a number of applications, ranging from medical treatments to biotechnology research. Fetal serum is derived from the blood of a calf during its last days. The process involves harvesting the fetus' blood during the calf's slaughter and refrigerating it in order to form a clot. The serum contains essential nutrients and growth factors that aid the growth and development of eukaryotic cells in culture.
To Get Complete Industry Insights, Grab Sample PDF Copy Here: https://bit.ly/3Ra4Pof
Increasing demand for fetal calf serum to supplement the growth of medium in cell culture as it has a high content of embryonic growth promoting factors is driving the formula fed calf serum market growth. The increasing number of contract research organizations especially across the Asia Pacific region is also fueling the formula fed calf serum market growth. The growing biopharmaceutical industry is again projected to foster the market growth of the fetal calf serum. According to the report by Pharma Manufacturing, the biopharma sector has seen incredible growth in recent decades. Total annual revenue has increased from about $4.4 billion in 1990 to about $275 billion in 2018, an increase of 6,250 percent, with biopharmaceuticals now more than 25 percent of the total pharmaceutical market. Also, increasing import and export of the fetal calf serum around the globe has further propelled the market growth of the fetal calf serum.
Europe is projected to gain significant growth over the forecast period and this is attributed to the strong presence of CRO in the region. According to Credevo, Europe was the second-largest dominating market globally for contract research organizations in the year 2018. The Europe CRO market is expected to reach US$ 22,157.62 Mn in 2025 from US$ 12,476.8 Mn in 2017.
Key Developments:
1. In September 2020, Peak Serum, Inc. — an independent supplier of life science laboratory products has partnered with the national, membership-based biotech network, BioLabs, for its annual cares for Cures grant program. With this initiative, a biological research lab is selected to receive a fetal bovine serum donation from Peak Serum.
2. In August 2020, Serum Institute of India enters into a partnership to accelerate the manufacture and delivery of Covid vaccines for India
No comments:
Post a Comment